Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M PEROU

Showing results (301-310 of 476) with videos related to

Pageof 48
Sort By:
The Journal of Clinical Investigation|October 12, 2021
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanomaBinita Chakraborty, Jovita Byemerwa, Jonathan Shepherd, et al.
Nature Communications|February 7, 2013
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancerLi-Jun Di, Jung S Byun, Madeline M Wong, et al.
Plos Medicine|December 7, 2016
Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Plos Medicine|January 10, 2017
Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Cancer Discovery|July 22, 2020
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Yang Zhang, Cheng Fan, et al.
Cancer Research Communications|February 14, 2022
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeuticsYang Gao, Elena B Kabotyanski, Jonathan H Shepherd, et al.
The Journal of Clinical Investigation|September 4, 2013
ErbB3 downregulation enhances luminal breast tumor response to antiestrogensMeghan M Morrison, Katherine Hutchinson, Michelle M Williams, et al.
JNCI Cancer Spectrum|January 14, 2021
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesHalei C Benefield, Katherine E Reeder-Hayes, Hazel B Nichols, et al.
Nature Communications|April 5, 2019
MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppressionYao Jiang, Yanqiong Zhang, Janet Y Leung, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Pageof 48

Showing results (301-310 of 476) with videos related to

Sort By:
Pageof 48
The Journal of Clinical Investigation|October 12, 2021
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanomaBinita Chakraborty, Jovita Byemerwa, Jonathan Shepherd, et al.
Nature Communications|February 7, 2013
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancerLi-Jun Di, Jung S Byun, Madeline M Wong, et al.
Plos Medicine|December 7, 2016
Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Plos Medicine|January 10, 2017
Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Cancer Discovery|July 22, 2020
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Yang Zhang, Cheng Fan, et al.
Cancer Research Communications|February 14, 2022
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeuticsYang Gao, Elena B Kabotyanski, Jonathan H Shepherd, et al.
The Journal of Clinical Investigation|September 4, 2013
ErbB3 downregulation enhances luminal breast tumor response to antiestrogensMeghan M Morrison, Katherine Hutchinson, Michelle M Williams, et al.
JNCI Cancer Spectrum|January 14, 2021
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological FeaturesHalei C Benefield, Katherine E Reeder-Hayes, Hazel B Nichols, et al.
Nature Communications|April 5, 2019
MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppressionYao Jiang, Yanqiong Zhang, Janet Y Leung, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Pageof 48